Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 5, 2005, Pages 622-631

  Lambert, John S ^a,b   Moye Jr , Jack ^c   Plaeger, Susan F ^d,g   Richard Stiehm, E ^d   Bethel, James ^e   Mofenson, Lynne M ^c   Mathieson, Bonnie ^f   Kagan, Jonathan ^g   Rosenblatt, Howard ^h   Paxton, Helene ^i,k   Suter, Hildie ⁱ   Landay, Alan ^j  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d MATTEL CHILDREN S HOSPITAL   (United States)

^e WESTAT   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^j RUSH MEDICAL COLLEGE   (United States)

^k Union Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; T LYMPHOCYTE; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DISEASE TRANSMISSION, VERTICAL; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; PHENOTYPE;

EID: 23944520868     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.5.622-631.2005     Document Type: Article

References (37)

1. Aldhous, M. C., G. M. Raab, J. Y. Mok, K. V. Doherty, A. G. Bird, K. S. Froebel. 1996. CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection. Pediatr. AIDS HIV Infect. 7:20-30.
2. Bayry, J., S. Lacroix-Desmazes, C. Carbonneil, N. Misra, V. Donkova, A. Pashov, A. Chevailler, L. Mouthon, B. Weill, P. Bruneval, M. D. Kazatchkine, S. V. Kaveri. 2003. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101:758-765.
3. Borkowsky, W., K. Krasinski, Y. Cao, Ho, D., H. Pollack, T. Moore, S. H. Chen, M. Allen, P. T. Tao. 1994. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J. Pediatr. 125:345-351.
4. Burgess, T., 2001. Determinants of transmission of HIV from mother to child. Clin. Obstet. Gynecol. 44:198-209.
5. Burns, D. N., P. Nourjah, H. Minkoff, J. Korelitz, R. J. Biggar, S. Landesman, A. Rubinstein, D. Wright, R. P. Nugent. 1996. Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am. J. Obstet. Gynecol. 174:1461-1468.
6. Burns, D. N., S. Landesman, D. J. Wright, D. Waters, R. M. Mitchell, A. Rubinstein, A. Willoughby, J. J. Goedert. 1997. Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1. J. Infect. Dis. 175:1206-1210.
7. Calvelli, T., T. N. Denny, H. Paxton, R. Gelman, J. Kagan. 1993. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 14: 702-715.
8. Denny, T., R. Yogev, R. Gelman, C. Skuza, J. Oleske, E. Chadwick, S. C. Cheng, E. Connor. 1992. Lymphocyte subsets in healthy children during the first 5 years of life. JAMA. 267:1484-1488.
9. Gallagher, K., M. Gorre, N. Harawa, M. Dillon, D. Wafer, E. R. Stiehm, Y. Bryson, D. Song, R. Dickover, S. Plaeger. 1997. Timing of lymphocyte activation in neonates infected with human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 4:742-747.
10. Giorgi, J. V., Ho, H. N., K. Hirji, C. C. Chou, L. E. Hultin, O'Rourke, S., L. Park, J. B. Margolick, J. Ferbas, J. P. Phair. 1994. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J. Infect. Dis. 170:775-781.
11. Ichiyama, T., Y. Ueno, H. Isumi, A. Niimi, T. Matsubara, S. Furukawa. 2004. An immunoglobulin agent (IVIG) inhibits NF-kappa B activation in cultured endothelial cells of coronary arteries in vitro. Inflamm. Res. 53:253-256.
12. Ichiyama, T., Y. Ueno, M. Hasegawa, A. Niimi, T. Matsubara, S. Furukawa. 2004. Intravenous immunoglobuiin inhibits NF-kappa B activation and affects Fc gamma receptor expression in monocytes/macrophages. N.-S. Arch. Pharmacol. 369:428-433.
13. Jennings, C., K. Rich, J. N. Siegel, A. Landay. 1994. A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. Clin. Immunol. Immunopathol. 71:8-13.
14. Kuhn, L., R. W. Steketee, J. Weedon, E. J. Abrams, G. Lambert, M. Bamji, E. Schoenbaum, J. Farley, S. R. Nesheim, P. Palumbo, R. J. Simonds, D. M. Thea. 1999. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J. Infect. Dis. 179:52-58.
15. Kwak, J. Y. H., F. M. Y. Kwak, S. W. Ainbinder, A. M. Ruiz, A. E. Beer. 1996. Elevated peripheral blood natural killer cells are effectively downregulated by Immunoglobuiin G infusion in women with recurrent spontaneous abortions. Am. J. Reprod. Immunol. 35:363-369.
16. Lambert, G., D. M. Thea, V. Pliner, R. W. Steketee, E. J. Abrams, P. Matheson, P. A. Thomas, B. Greenberg, T. M. Brown, M. Bamji, M. L. Kalish. 1997. Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group. J. Pediatr. 130:890-897.
17. Mahmoud, F., M. Diejomaoh, A. Omu, H. Abul, D. Haines. 2004. Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss. Gynecol. Obstet. Investig. 58:77-83.
18. Mazza, C., A. Ravaggi, A. Rodella, M. Duse, D. Padula, M. Lomini, F. Castelli, S. Bresciani, A. Albertini, E. Cariani. 1999. Influence of maternal CD4 levels on the predictive value of virus load over mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1). Study Group for Vertical Transmission. J. Med. Virol. 58:59-62.
19. McCloskey, T. W., N. Kohn, M. Lesser, S. Bakshi, S. Pahwa. 2001. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets. Cytometry 46:157-165.
20. Mikyas, Y., N. Aziz, N. Harawa, M. Gorre, N. Neagos, M. Nogueira, D. Wafer, M. Dillon, P. J. Boyer, Y. J. Bryson, S. Plaeger. 1997. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J. Reprod. Immunol. 33:157-170.
21. Mofenson, L. M., J. S. Lambert, E. R. Stiehm, J. Bethel, Meyer WA 3rd, J. Whitehouse, Moye J Jr., P. Reichelderfer, D. R. Harris, M. G. Fowler, B. J. Mathieson, G. J. Nemo. 1999. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N. Engl. J. Med. 341:385-393.
22. Nicholson, J., P. Kidd, F. Mandy, D. Livnat, J. Kagan. 1996. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry 26:227-230.
23. O'Shea, S., M. L. Newell, D. T. Dunn, M. C. Garcia-Rodriguez, I. Bates, J. Mullen, T. Rostron, K. Corbett, S. Aiyer, K. Butler, R. Smith, J. E. Banatvala. 1998. Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J. Med. Virol. 54:113-117.
24. Pitt, J., D. Brambilla, P. Reichelderfer, A. Landay, K. McIntosh, D. Burns, G. V. Hillyer, H. Mendez, M. G. Fowler. 1997. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study. J. Infect. Dis. 175:567-575.
25. Plaeger, S., S. Bermudez, Y. Mikyas, N. Harawa, R. Dickover, D. Mark, M. Dillon, Y. J. Bryson, P. J. Boyer, J. S. Sinsheimer, 1999. Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J. Infect. Dis. 179:1388-1394.
26. Radder, C. M., D. L. Roelen, van de E. M. Meer-Prins, F. H. Claas, H. H. Kanhai, A. Brand. 2004. The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am. J. Obstet. Gynecol. 191:815-820.
27. Rich, K. C., D. Brambilla, J. Pitt, J. Moye, E. Cooper, G. Hillyer, H. Mendez, M. G. Fowler, A. Landay. 1997. Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection. Clin. Immunol. Immunopathol. 85:273-281.
28. Rich, K. C., J. N. Siegel, C. Jennings, R. J. Rydman, A. L. Landay. 1995. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J. Infect. Dis. 172:1221-1227.
29. Rich, K. C., J. N. Siegel, C. Jennings, R. J. Rydman, A. L. Landay. 1997. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin. Diagn. Lab. Immunol. 4:358-361.
30. Rigal, D., C. Vermot-Desroches, S. Heitz, J. Bernaud, F. Alfonsi, J. C. Monier. 1994. NK Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules. Clin. Immunol. Immunopathol. 71:309-314.
31. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas standard deviation, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Specter SA; Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J. Allergy Clin. Immunol. 2003;112:973-980.
32. Stiehm, E. R., J. S. Lambert, L. M. Mofenson, J. Bethel, J. Whitehouse, R. Nugent, Moye J Jr., M. Glenn Fowler, B. J. Mathieson, P. Reichelderfer, G. J. Nemo, J. Korelitz, Meyer WA 3rd, C. V. Sapan, E. Jimenez, J. Gandia, G. Scott, O'Sullivan, M. J., A. Kovacs, A. Stek, W. T. Shearer, H. Hammill. 1999. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. J. Infect. Dis. 179:567-575.
33. Temmerman, M., A. O. Nyong'o, J. Bwayo, K. Fransen, M. Coppens, P. Piot. 1995. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am. J. Obstet. Gynecol. 172:700-705.
34. Toyoda, M., A. Pao, A. Petrosian, S. C. Jordan. 2003. Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am. J. Transplant. 3:156-166.
35. Tuomala, R. E., L. A. Kalish, C. Zorilla, H. Fox, W. Shearer, A. Landay, S. H. Vermund, S. Landesman, D. Burns. 1997. CD4+ Changes in total, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet. Gynecol. 89:967-974.
36. Vimercati, A., P. Greco, P. L. Lopalco, G. Loverro, J. R. Flore, S. Bettocchi, G. Angarano, L. Selvaggi. 2000. Immunological markers in HIV-infected pregnant and non-pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 90:37-41.
37. Watts, D. H., J. Lambert, E. R. Stiehm, D. R. Harris, J. Bethel, L. Mofenson, W. A. Meyer, B. Mathieson, M. G. Fowler, G. Nemo. 2003. PACTG 185 Study Team. Progression of HIV disease among women following delivery. J. Acquir. Immune Defic. Syndr. 33:585-593.